๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Initial alkylating agent chemotherapy in a leukemic hairy cell patient

โœ Scribed by Ellen Gaynor; Dr. Harvey M. Golomb; Jason McClellan

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
210 KB
Volume
16
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Leukemic meningitis in a patient with ha
Leukemic meningitis in a patient with hairy cell leukemia. A case report
โœ David W. Wolfe; Joseph A. Scopelliti; Bruce D. Boselli ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB ๐Ÿ‘ 2 views

Central nervous system involvement has not previously been described in patients with hairy cell leukemia (HCL). A patient is reported who presented with meningeal involvement as his initial symptom of HCL. Diagnosis was established by morphologic and cytochemical studies of his cerebrospinal fluid

Leukemic thyroiditis as the initial rela
Leukemic thyroiditis as the initial relapsing sign in a patient with acute lymphocytic leukemia and blast expression of the neural cell adhesion molecule
โœ Byrd, John C.; Dow, Nancy S.; Gaertner, Erich; Hargis, Jeffrey B.; Raber, Tracy ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 66 KB ๐Ÿ‘ 2 views

We report a patient with a history of T-cell ALL in remission who presented with symptoms and laboratory values consistent with subacute thyroiditis but was found to have leukemic thyroiditis as the first clinical manifestation of leukemic relapse. Bone marrow examination at this time demonstrated r

Single agent versus combination chemothe
Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : A meta-analysis of response, toxicity, and survival
โœ Rogerio C. Lilenbaum; Patricia Langenberg; Kay Dickersin ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 2 views

## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in